Contact

All Stories

  1. Using AI to predict how toxic “forever chemicals” (PFAS) are, based on their structure

    Article • Toxics, February 2026, MDPI AG

    Dr Antreas Afantitis

  2. Novel Dorsomorphin Derivatives: Molecular Modeling, Synthesis, and Bioactivity Evaluation

    Article • Biomolecules, January 2026, MDPI AG

    Dr Antreas Afantitis

  3. Using explainable AI to predict how iron-based nanoparticles affect cell health

    Article • Nanoscale Advances, January 2026, Royal Society of Chemistry

    Dr Antreas Afantitis, Prof. Iseult Lynch

  4. Using AI to predict how nanoparticles affect plant growth for safer and more sustainable agriculture

    Article • Environmental Science Nano, January 2026, Royal Society of Chemistry

    Dr Antreas Afantitis, Prof. Iseult Lynch

  5. Molecular dynamics simulations of temperature-dependent PET binding in PETase, ThermoPETase, and FAST-PETase

    Article • RSC Advances, January 2026, Royal Society of Chemistry

    Dr Antreas Afantitis, Prof. Iseult Lynch

  6. Building realistic nanoparticles from crystal data using an easy web-based tool

    Article • Journal of Chemical Information and Modeling, December 2025, American Chemical Society (ACS)

    Dr Antreas Afantitis, Prof. Iseult Lynch

  7. Repurposing Drug Explorer (ReDEx): A Tool for Integrating Disease Networks, Drug Similarity Algorithms and Functional Exploration Powered by Enalos Cloud Platform

    Article • Journal of Molecular Biology, December 2025, Elsevier

    Dr Antreas Afantitis

  8. How environmental chemicals bind to hormone receptors: insights from computer simulations

    Article • Journal of Chemical Information and Modeling, October 2025, American Chemical Society (ACS)

    Dr Antreas Afantitis

  9. How everyday plastic chemicals (phthalates) may affect human fertility and reproductive health

    Article • International Journal of Molecular Sciences, September 2025, MDPI AG

    Dr Antreas Afantitis

  10. Effect of pH, Temperature, Molecular Weight and Salt Concentration on the Structure and Hydration of Short Poly(N,N-dimethylaminoethyl methacrylate) Chains in Dilute Aqueous Solutions: A Combined Experimental and Molecular Dynamics Study

    Article • Polymers, August 2025, MDPI AG

    Dr Antreas Afantitis

  11. How tiny enzyme changes can help break down plastic more efficiently

    Article • International Journal of Molecular Sciences, August 2025, MDPI AG

    Prof. Iseult Lynch, Dr Antreas Afantitis

  12. Wisdom of Crowds for Supporting the Safety Evaluation of Nanomaterials

    Article • Environmental Science & Technology, July 2025, American Chemical Society (ACS)

    Prof. Hélder Santos, Prof. Iseult Lynch, Dr Antreas Afantitis

  13. Discovery of Novel Allosteric Inhibitor Hits for Insulin-Regulated Aminopeptidase Provides Insights on Enzymatic Mechanism

    Article • ACS Omega, April 2025, American Chemical Society (ACS)

    Dr Antreas Afantitis

  14. A fast online tool to predict how proteins stick to nanoparticles

    Article • Journal of Chemical Information and Modeling, March 2025, American Chemical Society (ACS)

    Prof. Iseult Lynch, Dr Antreas Afantitis

  15. A simple online tool to predict where particles end up in the human lungs

    Article • Environmental Science Nano, January 2025, Royal Society of Chemistry

    Prof. Iseult Lynch, Dr Antreas Afantitis

  16. Using computer models to improve how nanoparticles deliver drugs in the body

    Article • RSC Sustainability, January 2025, Royal Society of Chemistry

    Prof. Iseult Lynch, Dr Antreas Afantitis

  17. A web tool to build and analyze nanoparticles at the atomic level

    Article • Computational and Structural Biotechnology Journal, December 2024, Elsevier

    Prof. Iseult Lynch, Dr Antreas Afantitis

  18. A user-friendly online platform for predicting chemical and nanomaterial safety and properties

    Article • September 2024, ACM (Association for Computing Machinery)

    Dr Antreas Afantitis

  19. Examining Hemin and its Derivatives: Induction of Heme-Oxygenase-1 Activity and Oxidative Stress in Breast Cancer Cells through Collaborative Experimental Analysis and Molecular Dynamics Simulations

    Article • Journal of Medicinal Chemistry, August 2024, American Chemical Society (ACS)

    Dr Antreas Afantitis

  20. Natural compounds that may help reduce nicotine addiction by slowing its breakdown in the body

    Article • International Journal of Molecular Sciences, July 2024, MDPI AG

    Dr Antreas Afantitis

  21. ERAP Inhibitors in Autoimmunity and Immuno-Oncology: Medicinal Chemistry Insights

    Article • Journal of Medicinal Chemistry, July 2024, American Chemical Society (ACS)

    Dr Antreas Afantitis

  22. Using AI to predict how strongly new drugs activate a key metabolic receptor

    Article • International Journal of Molecular Sciences, May 2024, MDPI AG

    Prof. Iseult Lynch, Dr Antreas Afantitis

  23. Are iron-based nanoparticles safe for cancer treatment? Insights from lab studies

    Article • Nanomaterials, April 2024, MDPI AG

    Prof. Iseult Lynch, Dr Antreas Afantitis

  24. Exploring the Binding Effects of Natural Products and Antihypertensive Drugs on SARS-CoV-2: An In Silico Investigation of Main Protease and Spike Protein

    Article • International Journal of Molecular Sciences, November 2023, MDPI AG

    Dr Antreas Afantitis

  25. How artificial intelligence is transforming drug discovery—and why real-world testing still matters

    Article • International Journal of Molecular Sciences, March 2023, MDPI AG

    Dr Antreas Afantitis

  26. An In Vitro Dosimetry Tool for the Numerical Transport Modeling of Engineered Nanomaterials Powered by the Enalos RiskGONE Cloud Platform

    Article • Nanomaterials, November 2022, MDPI AG

    Prof. Iseult Lynch, Dr Antreas Afantitis

  27. Precision Medicine Approaches with Metabolomics and Artificial Intelligence

    Article • International Journal of Molecular Sciences, September 2022, MDPI AG

    Dr Antreas Afantitis

  28. European Registry of Materials: global, unique identifiers for (undisclosed) nanomaterials

    Article • Journal of Cheminformatics, August 2022, Springer Science + Business Media

    Professor Dave A Winkler, Prof. Iseult Lynch, Dr Antreas Afantitis

  29. Representing and describing nanomaterials in predictive nanoinformatics

    Article • Nature Nanotechnology, August 2022, Springer Science + Business Media

    Prof. Iseult Lynch, Dr Antreas Afantitis

  30. Towards an in silico integrated approach for testing and assessment of nanomaterials: from predicted indoor air concentrations to lung dose and biodistribution

    Article • Environmental Science Nano, January 2022, Royal Society of Chemistry

    Prof. Iseult Lynch, Dr Antreas Afantitis

  31. In Silico Identification and Evaluation of Natural Products as Potential Tumor Necrosis Factor Function Inhibitors Using Advanced Enalos Asclepios KNIME Nodes

    Article • International Journal of Molecular Sciences, September 2021, MDPI AG

    Dr Antreas Afantitis

  32. Importance of Surface Topography in Both Biological Activity and Catalysis of Nanomaterials: Can Catalysis by Design Guide Safe by Design?

    Article • International Journal of Molecular Sciences, August 2021, MDPI AG

    Dr Antreas Afantitis

  33. Manually curated transcriptomics data collection for toxicogenomic assessment of engineered nanomaterials

    Article • Scientific Data, February 2021, Springer Science + Business Media

    Prof. Iseult Lynch, Dr Antreas Afantitis

  34. Advances in De Novo Drug Design: From Conventional to Machine Learning Methods

    Article • International Journal of Molecular Sciences, February 2021, MDPI AG

    Prof. Iseult Lynch, Dr Antreas Afantitis

  35. Editorial for the Special Issue From Nanoinformatics to Nanomaterials Risk Assessment and Governance

    Article • Nanomaterials, January 2021, MDPI AG

    Prof. Iseult Lynch, Dr Antreas Afantitis

  36. A first proposal for how to represent nanomaterials' composition and structure in a standardised way

    Article • Nanomaterials, December 2020, MDPI AG

    Prof. Iseult Lynch, Professor Dave A Winkler, Dr Antreas Afantitis

  37. Metadata Stewardship in Nanosafety Research: Community-Driven Organisation of Metadata Schemas to Support FAIR Nanoscience Data

    Article • Nanomaterials, October 2020, MDPI AG

    Prof. Iseult Lynch, Dr Antreas Afantitis

  38. Structure-Based Discovery of Novel Chemical Classes of Autotaxin Inhibitors

    Article • International Journal of Molecular Sciences, September 2020, MDPI AG

    Dr Antreas Afantitis

  39. Development of Deep Learning Models for Predicting the Effects of Exposure to Engineered Nanomaterials on Daphnia magna

    Article • Small, June 2020, Wiley

    Prof. Iseult Lynch, Dr Antreas Afantitis

  40. Transcriptomics in Toxicogenomics, Part II: Preprocessing and Differential Expression Analysis for High Quality Data

    Article • Nanomaterials, May 2020, MDPI AG

    Dr Antreas Afantitis

  41. Transcriptomics in Toxicogenomics, Part I: Experimental Design, Technologies, Publicly Available Data, and Regulatory Aspects

    Article • Nanomaterials, April 2020, MDPI AG

    Dr Antreas Afantitis

  42. Transcriptomics in Toxicogenomics, Part III: Data Modelling for Risk Assessment

    Article • Nanomaterials, April 2020, MDPI AG

    Dr Antreas Afantitis

  43. Nanoinformatics: Artificial Intelligence and Nanotechnology in the New Decade

    Article • Combinatorial Chemistry & High Throughput Screening, March 2020, Bentham Science Publishers

    Dr Antreas Afantitis

  44. Zeta‐Potential Read‐Across Model Utilizing Nanodescriptors Extracted via the NanoXtract Image Analysis Tool Available on the Enalos Nanoinformatics Cloud Platform

    Article • Small, March 2020, Wiley

    Prof. Iseult Lynch, Dr Antreas Afantitis

  45. Computer-Aided Drug Design of β-Secretase, γ-Secretase and Anti-Tau Inhibitors for the Discovery of Novel Alzheimer’s Therapeutics

    Article • International Journal of Molecular Sciences, January 2020, MDPI AG

    Dr Antreas Afantitis

  46. MS-275 Chemical Analogues Promote Hemoglobin Production and Erythroid Differentiation of K562 Cells

    Article • Hemoglobin, March 2019, Taylor & Francis

    Dr Antreas Afantitis, Dr Georgia Melagraki, Panayiotis Koutentis

  47. A safe-by-design tool for functionalised nanomaterials through the Enalos Nanoinformatics Cloud platform

    Article • Nanoscale Advances, January 2019, Royal Society of Chemistry

    Prof. Iseult Lynch, Dr Antreas Afantitis

  48. Read-across predictions of nanoparticle hazard endpoints: a mathematical optimization approach

    Article • Nanoscale Advances, January 2019, Royal Society of Chemistry

    Dr Antreas Afantitis

  49. Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials

    Article • Medicinal Research Reviews, November 2018, Wiley

    Dr Antreas Afantitis

  50. A nanoinformatics decision support tool for the virtual screening of gold nanoparticle cellular association using protein corona fingerprints

    Article • Nanotoxicology, September 2018, Taylor & Francis

    Dr Antreas Afantitis, Dr Georgia Melagraki, Prof. Iseult Lynch

  51. In Silico Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)

    Article • Frontiers in Pharmacology, July 2018, Frontiers

    Dr Antreas Afantitis

  52. Current Status and Future Prospects of Small–molecule Protein–protein Interaction (PPI) Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)

    Article • Current Topics in Medicinal Chemistry, July 2018, Bentham Science Publishers

    Dr Georgia Melagraki, thomas mavromoustakos, Dr Antreas Afantitis, Elias Eliopoulos, Dr Christos Papaneophytou

  53. Hydroxamic Acids Constitute a Novel Class of Autotaxin Inhibitors that Exhibit in Vivo Efficacy in a Pulmonary Fibrosis Model

    Article • Journal of Medicinal Chemistry, April 2018, American Chemical Society (ACS)

    Dr Antreas Afantitis

  54. Computational toxicology: From cheminformatics to nanoinformatics

    Article • Food and Chemical Toxicology, February 2018, Elsevier

    Dr Antreas Afantitis

  55. Consensus Predictive Model for Human K562 Cell Growth Inhibition through Enalos Cloud Platform

    Article • January 2018, Wiley

    Dr Antreas Afantitis

  56. Enalos Suite: New Cheminformatics Platform for Drug Discovery and Computational Toxicology

    Article • January 2018, Springer Science + Business Media

    Dr Antreas Afantitis

  57. Enalos+ KNIME Nodes: New Cheminformatics Tools for Drug Discovery

    Article • January 2018, Springer Science + Business Media

    Dr Antreas Afantitis

  58. MouseTox: An online toxicity assessment tool for small molecules through Enalos Cloud platform

    Article • Food and Chemical Toxicology, December 2017, Elsevier

    Dr Antreas Afantitis

  59. Aqueous Solubility Enhancement for Bioassays of Insoluble Inhibitors and QSPR Analysis: A TNF-α Study

    Article • SLAS DISCOVERY, June 2017, SAGE Publications

    Dr Antreas Afantitis

  60. Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)

    Article • PLoS Computational Biology, April 2017, PLOS

    Dr Antreas Afantitis

  61. Searching for Novel Janus Kinase-2 Inhibitors Using a Combination of Pharmacophore Modeling, 3D-QSAR Studies and Virtual Screening

    Article • Mini-Reviews in Medicinal Chemistry, January 2017, Bentham Science Publishers

    Dr Antreas Afantitis, Dr Georgia Melagraki

  62. Development of a Predictive Pharmacophore Model and a 3D-QSAR Study for an in silico Screening of New Potent Bcr-Abl Kinase Inhibitors

    Article • Mini-Reviews in Medicinal Chemistry, January 2017, Bentham Science Publishers

    Dr Antreas Afantitis, Dr Georgia Melagraki

  63. Computer Aided Drug Design Approaches for Identification of Novel Autotaxin (ATX) Inhibitors

    Article • Current Medicinal Chemistry, June 2016, Bentham Science Publishers

    Dr Antreas Afantitis, thomas mavromoustakos

  64. Editorial: Towards Open Access for Cheminformatics

    Article • Combinatorial Chemistry & High Throughput Screening, April 2016, Bentham Science Publishers

    Dr Antreas Afantitis

  65. Open-Source Chemoinformatics Software

    Article • January 2016, Springer Science + Business Media

    Dr Antreas Afantitis

  66. Open Source Chemoinformatics Software including KNIME Analytics Platform

    Article • January 2016, Springer Science + Business Media

    Dr Antreas Afantitis

  67. A Risk Assessment Tool for the Virtual Screening of Metal Oxide Nanoparticles through Enalos InSilicoNano Platform

    Article • Current Topics in Medicinal Chemistry, June 2015, Bentham Science Publishers

    Dr Georgia Melagraki, Dr Antreas Afantitis

  68. Searching for anthranilic acid-based thumb pocket 2 HCV NS5B polymerase inhibitors through a combination of molecular docking, 3D-QSAR and virtual screening

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, June 2015, Taylor & Francis

    Dr Antreas Afantitis

  69. Editorial (Thematic Issue: Advances in Cheminformatics: Drug Discovery, Computational Toxicology and Nanomaterials (Part II))

    Article • Combinatorial Chemistry & High Throughput Screening, April 2015, Bentham Science Publishers

    Dr Antreas Afantitis

  70. Rational Drug Design Paradigms: The Odyssey for Designing Better Drugs

    Article • Combinatorial Chemistry & High Throughput Screening, April 2015, Bentham Science Publishers

    Dr Antreas Afantitis, thomas mavromoustakos, Tahsin F Kellici, Dr Sotiris K Hadjikakou

  71. Editorial (Thematic Issue: Advances in Cheminformatics: Drug Discovery, Computational Toxicology and Nanomaterials (Part I))

    Article • Combinatorial Chemistry & High Throughput Screening, April 2015, Bentham Science Publishers

    Dr Georgia Melagraki, Dr Antreas Afantitis

  72. Meet our Editorial Board Members

    Article • Combinatorial Chemistry & High Throughput Screening, April 2015, Bentham Science Publishers

    Dr Georgia Melagraki, Dr Antreas Afantitis

  73. Exploiting ChEMBL database to identify indole analogs as HCV replication inhibitors

    Article • Methods, January 2015, Elsevier

    Dr Antreas Afantitis, thomas mavromoustakos

  74. Stability and binding effects of silver(I) complexes at lipoxygenase-1

    Article • Journal of Enzyme Inhibition and Medicinal Chemistry, November 2014, Taylor & Francis

    Dr Antreas Afantitis, Dr Sotiris K Hadjikakou

  75. Editorial

    Article • Combinatorial Chemistry & High Throughput Screening, June 2014, Bentham Science Publishers

    Dr Antreas Afantitis

  76. Antiproliferative novel isoxazoles: Modeling, virtual screening, synthesis, and bioactivity evaluation

    Article • European Journal of Medicinal Chemistry, June 2014, Elsevier

    Dr Antreas Afantitis

  77. Enalos InSilicoNano platform: an online decision support tool for the design and virtual screening of nanoparticles

    Article • RSC Advances, January 2014, Royal Society of Chemistry

    Dr Georgia Melagraki, Dr Antreas Afantitis

  78. Editorial

    Article • Combinatorial Chemistry & High Throughput Screening, November 2013, Bentham Science Publishers

    Dr Antreas Afantitis

  79. Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches

    Article • Toxicology and Applied Pharmacology, October 2013, Elsevier

    Dr Antreas Afantitis

  80. Enalos KNIME nodes: Exploring corrosion inhibition of steel in acidic medium

    Article • Chemometrics and Intelligent Laboratory Systems, April 2013, Elsevier

    Dr Antreas Afantitis

  81. Rational design, efficient syntheses and biological evaluation of N,N′-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers

    Article • European Journal of Medicinal Chemistry, April 2013, Elsevier

    Dr Antreas Afantitis

  82. Comparative study of the AT1 receptor prodrug antagonist candesartan cilexetil with other sartans on the interactions with membrane bilayers

    Article • Biochimica et Biophysica Acta (BBA) - Biomembranes, December 2012, Elsevier

    Dr Antreas Afantitis

  83. Comparative Binding Effects of Aspirin and Anti-Inflammatory Cu Complex in the Active Site of LOX-1

    Article • Journal of Chemical Information and Modeling, November 2012, American Chemical Society (ACS)

    Dr Sotiris K Hadjikakou, Dr Antreas Afantitis

  84. Molecular Modeling on Pyrimidine-Urea Inhibitors of TNF-α Production: An Integrated Approach Using a Combination of Molecular Docking, Classification Techniques, and 3D-QSAR CoMSIA

    Article • Journal of Chemical Information and Modeling, March 2012, American Chemical Society (ACS)

    Dr Antreas Afantitis

  85. Ligand and Structure Based Virtual Screening Strategies for Hit-Finding and Optimization of Hepatitis C Virus (HCV) Inhibitors

    Article • Current Medicinal Chemistry, June 2011, Bentham Science Publishers

    Dr Antreas Afantitis

  86. Ligand - based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen maps and Counterpropagation Artificial Neural Networks

    Article • European Journal of Medicinal Chemistry, February 2011, Elsevier

    Dr Antreas Afantitis

  87. Functionalized 4-Hydroxy Coumarins: Novel Synthesis, Crystal Structure and DFT Calculations

    Article • Molecules, January 2011, MDPI AG

    Dr Antreas Afantitis

  88. In Silico Exploration for Identifying Structure-Activity Relationship of MEK Inhibition and Oral Bioavailability for Isothiazole Derivatives

    Article • Chemical Biology & Drug Design, October 2010, Wiley

    Dr Antreas Afantitis

  89. Collaborative development of predictive toxicology applications

    Article • Journal of Cheminformatics, August 2010, Springer Science + Business Media

    Dr Antreas Afantitis

  90. Synthesis and evaluation of the antioxidant and anti-inflammatory activity of novel coumarin-3-aminoamides and their alpha-lipoic acid adducts

    Article • European Journal of Medicinal Chemistry, July 2009, Elsevier

    Dr Antreas Afantitis

  91. A combined LS-SVM & MLR QSAR workflow for predicting the inhibition of CXCR3 receptor by quinazolinone analogs

    Article • Molecular Diversity, May 2009, Springer Science + Business Media

    Dr Antreas Afantitis

  92. Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors

    Article • Molecular Diversity, February 2009, Springer Science + Business Media

    Dr Antreas Afantitis

  93. A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureas

    Article • European Journal of Medicinal Chemistry, February 2009, Elsevier

    Dr Antreas Afantitis

  94. Development and Evaluation of a QSPR Model for the Prediction of Diamagnetic Susceptibility

    Article • QSAR & Combinatorial Science, April 2008, Wiley

    Dr Antreas Afantitis

  95. Identification of a series of novel derivatives as potent HCV inhibitors by a ligand-based virtual screening optimized procedure

    Article • Bioorganic & Medicinal Chemistry, December 2007, Elsevier

    Dr Antreas Afantitis

  96. Design and Synthesis of Novel Quinolinone-3-aminoamides and Their α-Lipoic Acid Adducts as Antioxidant and Anti-inflammatory Agents

    Article • Journal of Medicinal Chemistry, May 2007, American Chemical Society (ACS)

    Dr Antreas Afantitis

  97. Optimization of biaryl piperidine and 4-amino-2-biarylurea MCH1 receptor antagonists using QSAR modeling, classification techniques and virtual screening

    Article • Journal of Computer-Aided Molecular Design, March 2007, Springer Science + Business Media

    Dr Antreas Afantitis

  98. A Novel QSAR Model for Evaluating and Predicting the Inhibition Activity of Dipeptidyl Aspartyl Fluoromethylketones

    Article • QSAR & Combinatorial Science, October 2006, Wiley

    Dr Antreas Afantitis

  99. A novel QSAR model for predicting induction of apoptosis by 4-aryl-4H-chromenes

    Article • Bioorganic & Medicinal Chemistry, October 2006, Elsevier

    Dr Antreas Afantitis

  100. A novel simple QSAR model for the prediction of anti-HIV activity using multiple linear regression analysis

    Article • Molecular Diversity, August 2006, Springer Science + Business Media

    Dr Antreas Afantitis

  101. A Novel RBF Neural Network Training Methodology to Predict Toxicity to Vibrio Fischeri

    Article • Molecular Diversity, June 2006, Springer Science + Business Media

    Dr Antreas Afantitis

  102. A novel QSPR model for predicting θ (lower critical solution temperature) in polymer solutions using molecular descriptors

    Article • Journal of Molecular Modeling, May 2006, Springer Science + Business Media

    Dr Antreas Afantitis

  103. Prediction of intrinsic viscosity in polymer–solvent combinations using a QSPR model

    Article • Polymer, April 2006, Elsevier

    Dr Antreas Afantitis

  104. QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices

    Article • Bioorganic & Medicinal Chemistry, February 2006, Elsevier

    Dr Antreas Afantitis

  105. Investigation of substituent effect of 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides on CCR5 binding affinity using QSAR and virtual screening techniques

    Article • Journal of Computer-Aided Molecular Design, February 2006, Springer Science + Business Media

    Dr Antreas Afantitis

  106. Prediction of toxicity using a novel RBF neural network training methodology

    Article • Journal of Molecular Modeling, November 2005, Springer Science + Business Media

    Dr Antreas Afantitis

  107. Prediction of high weight polymers glass transition temperature using RBF neural networks

    Article • Journal of Molecular Structure THEOCHEM, March 2005, Elsevier

    Dr Antreas Afantitis

  108. Novel Short-Step Synthesis of Functionalized γ-Phenyl-β-hydroxybutenoates and Their Cyclization to 4-Hydroxycoumarins via the N-Hydroxybenzotriazole Methodology.

    Article • ChemInform, January 2005, Wiley

    Dr Antreas Afantitis

  109. Novel Short-Step Synthesis of Functionalized γ-Phenyl-β-hydroxybutenoates and their Cyclization to 4-Hydroxycoumarins via the N-Hydroxybenzotriazole Methodology

    Article • Synthesis, July 2004, Thieme Publishing Group

    Dr Antreas Afantitis

  110. Development of nonlinear quantitative structure-activity relationships using rbf networks and evolutionary computing

    Article • January 2004, Elsevier

    Dr Antreas Afantitis

  111. Cyclisation of Novel Amino Oxo Esters to Tetramic Acids− Density Functional Theory Study of the Reaction Mechanism

    Article • European Journal of Organic Chemistry, December 2003, Wiley

    Dr Antreas Afantitis

  112. Quantitative Nanostructure-Activity Relationship Models for the Risk Assessment of NanoMaterials

    Article • IGI Global

    Dr Antreas Afantitis, thomas mavromoustakos